REGULATION A+ FUNDRAISING VIDEO

 

MAKING AN IMPACT
ON THE OPIOD EPIDEMIC

 
 

01
BACKGROUND

InSitu Biologics, LLC is an emerging drug delivery company focusing on development of new and proprietary treatments using its Matrix™ BioHydrogel.

Their lead product, AnestaGel™, is a long-lasting and long-acting non-opiate painkiller, targeted for use in peri-operative regional pain management. AnestaGel™ uses a novel approach to delivering sustained-released analgesics into the target tissue via the Matrix™ BioHydrogel platform, which is a tunable, biocompatible, and pH neutral platform. This allows AnestaGel™ to provide target site-specific, non-migratory placement, a flexible and high dose drug-load reservoir capacity, and a tunable and predictable pharmacological effect.

 

 

 

Screen Shot 2019-07-19 at 8.19.27 AM.png
 

02
OBJECTIVE

InSitu approached DEFCON to produce a Corporate Overview/Regulation A+ Fundraising video.

THE OBJECTIVE - ANESTAGEL IS A DISRUPTER IN THE MEDICAL INDUSTRY

THE POSITIONING IDEA - A NON-OPID ALTERNATIVE TO POST-OP PATIENTS

 
 

03
STRATEGY

Our team strategized on how we could best tell InSitu's story and the their industry disrupting post-operative product AnestaGel.

Defcon strategized on three key take-aways that the viewer will be inspired by when watching and hearing InSitu's story and mission as a company. We wanted to showcase the benefits and value of why AnestaGel is a game changer.

 

 

Screen Shot 2019-07-19 at 8.39.52 AM.png
 

 

04
PRODUCTION

 

To begin the production, the CEO of InSitu Biologics flew out to San Diego to sit down with us for the first initial interview. This is where we get a deep understanding of what InSitu Biologics stands for as a company. After a few hours of speaking with Jim the CEO of InSitu, we wrapped our Day 1 shoot and began the pre-production for the second half of the InSitu production.

Our production team flew out to St. Paul, Minnesota to film at the InSitu lab and interview the other co-founders of InSitu.  We arrived in St. Paul Monday night and prepared all of the production equipment for Day 2. We arrived at the Heritage Wealth office on a snowy morning in Minnesota to capture the remaining interviews. After a full day of interviewing the InSitu team, we wrapped our Day 1 film shoot. 

On our 3rd and final production shoot in Minnesota to wrap the filming on the InSitu fundraising video. We met with the chief of science, Bill Taylor, to interview him about his process of inventing AnestaGel. We met at the InSitu Biologics lab located outside of St. Paul. After we finished interviewing with Bill Taylor, we finished by capturing the process of how they create the AnestaGel.

Using state of the art post-production software our team was able to bring InSitu Biologics story to life.

 
 

 

05
FINAL DELIVERABLES

 

The final deliverables consisted of a 5:30min and 2:30min Company Overview video to be used in their Regulation A+ Fundraising round. We also captured product photography shots of the AnestaGel application. This content to be used for capital fundraising and various marketing elements including online advertising placement, media partner content, and Instagram marketing.

 

 
 

 

06
BEHIND THE SCENES

 
Screen Shot 2019-07-19 at 8.19.43 AM.png